Patients with treatment-resistant CLL respond positively to stem cell transplants
Wednesday, July 7, 2010 - 00:14
in Health & Medicine
Allogeneic (donor-derived) stem cell transplant may be a promising option for patients with treatment-resistant chronic lymphocytic leukemia (CLL), regardless of the patient's underlying genetic abnormalities, according to the results of a new study.